In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10466669.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
With the dopaminergic presynaptic ligand FP-CIT and single photon emission tomography we have shown a severe dopaminergic degeneration in a patient with a necropsy confirmed diagnosis of dementia with Lewy bodies (DLB). We suggest that functional imaging of the nigrostriatal dopamine pathway helps to distinguish DLB from Alzheimer's disease during life.
Medical subject headings
- Brain
- Dementia
- Dopamine
- Lewy Bodies
- Nerve Degeneration